Channeling the ire of constituents and drawing from personal experience,senators chastised drug company executives Tuesday over the tall cost of prescription medications, while the CEOs warned that government price controls could stifle breakthroughs on diseases like Alzheimer’s. The Senate …
Source: insurancejournal.com